Abstract：Objective To study the clinical effect of Vancomycin in the treatment of severe pneumonia infected by Gram-positive cocci. Methods Eighty patients with severe pneumonia infected by Gram-positive cocci treated in our hospital from April 2016 to March 2019 were selected as the study subjects. The patients were divided into the control group and the observation group according to the random number table method, with 40 cases in each group. Patients in the control group were treated with Levofloxacin, and in the observation group, patients were treated with Vancomycin. The therapeutic effects, bacterial clearance rate, and adverse reactions in two groups after treatment were compared. Results The total effective rate of the observation group was 95.00%, which was higher than that of the control group accounting for 75.00%, and the difference was statistically significant (P＜0.05). The total bacterial clearance rate of the observation group was 95.00%, which was higher than that of the control group accounting for 75.00%, with statistical significance (P＜0.05). The total incidence of adverse reactions in the observation group was 5.00%, which was lower than that in the control group accounting for 22.5%, with statistical significance (P＜0.05). Conclusion Vancomycin is effective in the treatment of severe pneumonia caused by gram-positive cocci. It is safe and effective, which has less adverse reactions.
李静； 丁金峰； 肖文香. 万古霉素治疗革兰阳性球菌感染重症肺炎的临床效果[J]. 中国当代医药, 2020, 27(7): 185-187.
LI Jing； DING Jin-feng； XIAO Wen-xiang. Clinical effect of Vancomycin in the treatment of severe pneumonia infected by Gram-positive cocci. 中国当代医药, 2020, 27(7): 185-187.
京公网安备 11010502046607号